![Wanlin Xia](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Dr. Wanlin Xia is Vice President-Analytical Chemistry at Asymchem Laboratories, Inc.
Dr. Xia was previously employed as a Principal by MannKind Corp., a Principal by Novartis Corp., and a Principal by Penwest Pharmaceuticals Co.
He received his MBA from Fairleigh Dickinson University and a doctorate degree from the University of Pittsburgh.
Antiguos cargos conocidos de Wanlin Xia.
Empresas | Cargo | Fin |
---|---|---|
Penwest Pharmaceuticals Co.
![]() Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Corporate Officer/Principal | - |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
MANNKIND CORPORATION | Corporate Officer/Principal | - |
Asymchem Laboratories, Inc.
![]() Asymchem Laboratories, Inc. BiotechnologyHealth Technology Asymchem Laboratories, Inc. operates as a holding company with interest in providing research-based contract manufacturing services. The firm’s services include core technologies, flow chemistry, biotechnology, peptide API development, process research and development, contract manufacturing, pharmaceutical development, analytical, FTE services, regulatory, project management and supply chain services. The company was founded by Hao Hong in 1995 and is headquartered in Morrisville, NC. | Corporate Officer/Principal | - |
Formación de Wanlin Xia.
University of Pittsburgh | Doctorate Degree |
Fairleigh Dickinson University | Masters Business Admin |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
MANNKIND CORPORATION | Health Technology |
Empresas privadas | 3 |
---|---|
Asymchem Laboratories, Inc.
![]() Asymchem Laboratories, Inc. BiotechnologyHealth Technology Asymchem Laboratories, Inc. operates as a holding company with interest in providing research-based contract manufacturing services. The firm’s services include core technologies, flow chemistry, biotechnology, peptide API development, process research and development, contract manufacturing, pharmaceutical development, analytical, FTE services, regulatory, project management and supply chain services. The company was founded by Hao Hong in 1995 and is headquartered in Morrisville, NC. | Health Technology |
Novartis Corp.
![]() Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Penwest Pharmaceuticals Co.
![]() Penwest Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology Penwest Pharmaceuticals Co. is a speciality pharmaceutical company focused on the development and commercialisation of therapies for the treatment of neurological disorders. Its oral controlled release technologies are also available for the development and commercialisation of products in multiple therapeutic areas. The company was founded in 1991 and is headquartered in Patterson, NY. | Health Technology |
- Bolsa de valores
- Insiders
- Wanlin Xia